Su‐Mei He
Biographic Data
| ID | 7956236 |
|---|---|
| NAME | Su‐Mei He |
| GIVEN NAMES | Su‐Mei |
| FAMILY NAME | He |
| SIGNATURE | HE S M |
| AFFILIATIONS | Nanjing University |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Drug-drug interaction of paroxetine on olanzapine and initial dosage optimization in patients with major depressive disorder based on population pharmacokinetics
This has been the first case to establish olanzapine population pharmacokinetics in patients with major depressive disorder. In addition, the present study innovatively clarified that paroxetine affected olanzapine population pharmacokinetics and initial dosage in patients with major depressive disorder
Population pharmacokinetics modelling to predict DDI from zopiclone on clozapine in schizophrenia patients
When zopiclone was taken concurrently, clozapine dosage need to be reduced. Based on this, schizophrenia patients individualized dosage adjustment was recommended
Drug–drug interaction and initial dosage optimization of aripiprazole in patients with schizophrenia based on population pharmacokinetics
This is the first investigation of the effects of fluoxetine on aripiprazole via drug-drug interaction. The optimal aripiprazole initial dosage is recommended in patients with schizophrenia
Model-informed precision dosing of quetiapine in bipolar affective disorder patients
The present study, for the first time, recommended an initial dose of quetiapine in patients with BAD based on MIPD and real-world data, providing an individualized reference for the administration of quetiapine in these patients
No prominent works on this page.
Drug–drug interaction and initial dosage optimization of aripiprazole in patients with schizophrenia based on population pharmacokinetics
This is the first investigation of the effects of fluoxetine on aripiprazole via drug-drug interaction. The optimal aripiprazole initial dosage is recommended in patients with schizophrenia
Model-informed precision dosing of quetiapine in bipolar affective disorder patients
The present study, for the first time, recommended an initial dose of quetiapine in patients with BAD based on MIPD and real-world data, providing an individualized reference for the administration of quetiapine in these patients
Drug-drug interaction of paroxetine on olanzapine and initial dosage optimization in patients with major depressive disorder based on population pharmacokinetics
This has been the first case to establish olanzapine population pharmacokinetics in patients with major depressive disorder. In addition, the present study innovatively clarified that paroxetine affected olanzapine population pharmacokinetics and initial dosage in patients with major depressive disorder
Population pharmacokinetics modelling to predict DDI from zopiclone on clozapine in schizophrenia patients
When zopiclone was taken concurrently, clozapine dosage need to be reduced. Based on this, schizophrenia patients individualized dosage adjustment was recommended
Schizophrenia (object-oriented programming (4 works) · Bipolar Disorder and Treatment (3 works) · Medicine (3 works) · Pharmacokinetics (3 works) · Pharmacology (3 works) · Population (3 works) · Psychiatry (3 works) · Schizophrenia research and treatment (3 works) · Epilepsy research and treatment (2 works) · Mood (2 works)